Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Mattes

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1985
Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarian carcinomas and other human tumorsC Cordon-Cardo, M J Mattes, M R Melamed, et al.
Biochemistry|December 17, 1985
Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinantsK Furukawa, H Clausen, S Hakomori, et al.
The Journal of Experimental Medicine|October 1, 1984
Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibodyF X Real, M J Mattes, A N Houghton, et al.
Cancer Research|December 15, 1987
Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cellsM J Mattes, K Look, K Furukawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptidesR Stein, S V Govindan, M J Mattes, et al.
International Journal of Cancer|May 2, 1997
The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibodyM J Mattes, L B Shih, S V Govindan, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Localization of complement-fixing cytotoxic monoclonal antibodies to subcutaneous tumors and liver metastases in a syngeneic immunocompetent rat colon carcinoma modelK P O'Boyle, M J Mattes, E R Sigurdson, et al.
Cancer Research|August 1, 1996
Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colonR D Blumenthal, R Stein, R M Sharkey, et al.
European Journal of Immunology|April 1, 1997
The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissuesF A Spring, C H Holmes, K L Simpson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsetsJ G Cairncross, M J Mattes, H R Beresford, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1985
Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarian carcinomas and other human tumorsC Cordon-Cardo, M J Mattes, M R Melamed, et al.
Biochemistry|December 17, 1985
Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinantsK Furukawa, H Clausen, S Hakomori, et al.
The Journal of Experimental Medicine|October 1, 1984
Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibodyF X Real, M J Mattes, A N Houghton, et al.
Cancer Research|December 15, 1987
Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cellsM J Mattes, K Look, K Furukawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptidesR Stein, S V Govindan, M J Mattes, et al.
International Journal of Cancer|May 2, 1997
The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibodyM J Mattes, L B Shih, S V Govindan, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Localization of complement-fixing cytotoxic monoclonal antibodies to subcutaneous tumors and liver metastases in a syngeneic immunocompetent rat colon carcinoma modelK P O'Boyle, M J Mattes, E R Sigurdson, et al.
Cancer Research|August 1, 1996
Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colonR D Blumenthal, R Stein, R M Sharkey, et al.
European Journal of Immunology|April 1, 1997
The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissuesF A Spring, C H Holmes, K L Simpson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsetsJ G Cairncross, M J Mattes, H R Beresford, et al.
Pageof 8